Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Endocrinol.

Sec. Cardiovascular Endocrinology

The association of non-HDL-C, NHHR, RC, and RCII with coronary artery stenosis severity in patients with acute coronary syndrome combined with cardiometabolic multimorbidity

Provisionally accepted
Peng  ZhangPeng Zhang1Degang  MoDegang Mo1Chao  DongChao Dong2Wenhua  ZengWenhua Zeng2Nuo  LiNuo Li2Jiani  WuJiani Wu1Guoan  WangGuoan Wang3*Hongyan  DaiHongyan Dai3*
  • 1Qingdao University Qingdao Medical College, Qingdao, China
  • 2Shandong Second Medical University, Weifang, China
  • 3Qingdao Municipal Hospital Group, Qingdao, China

The final, formatted version of the article will be published soon.

Background Coronary heart disease, particularly acute coronary syndrome (ACS), is a significant public health concern, and its progression is expedited when combined with cardiometabolic multimorbidity (CMM). The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and remnant cholesterol inflammatory index (RCII) are novel lipid composite indices generated from non-high-density lipoprotein cholesterol (non-HDL-C) and remnant cholesterol (RC). This study examined the association between the aforementioned four indices and the degree of coronary artery stenosis (CAS) in individuals with ACS and CMM. Methods This retrospective cross-sectional study encompassed 298 patients diagnosed with ACS and CMM who underwent coronary angiography while hospitalized. Logistic regression models and restricted cubic spline analyses were used to investigate the association between non-HDL-C, NHHR, RC, and RCII with CAS. Two-stage logistic regression models were used to analyze threshold effects, while receiver operating characteristic analysis was conducted to test the predictive capability for severe CAS. Subgroup analyses were performed to evaluate risk among different demographic groups. Results Among the 298 participants, 150 (50.34%) had severe CAS. In multivariate logistic regression models, non-HDL-C, NHHR, RC, and RCII, when assessed per standard deviation, all exhibited a significant association with severe CAS. Among these, RCII had the strongest association with severe CAS (OR: 2.78, 95% CI 1.30-5.94), followed by NHHR (OR: 1.96, 95% CI 1.43-2.68). RCS analysis revealed a nonlinear relationship between RCII and severe CAS, with threshold effect analysis identifying an inflection point at 0.64. ROC analysis indicated that NHHR exhibited the greatest predictive capability, followed by RCII. The interaction test indicated no statistically significant difference in the association between the aforementioned four indices and CAS across subgroups. Conclusions Non-HDL-C, NHHR, RC, and RCII all showed a strong association with CAS in patients with ACS combined with CMM. RCII exhibited a nonlinear association with severe CAS, featuring an inflection point at 0.64.

Keywords: Acute Coronary Syndrome, multimorbidity, Coronary artery stenosis, Gensini score, non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio, Remnant Cholesterol Inflammatory Index

Received: 10 Sep 2025; Accepted: 20 Nov 2025.

Copyright: © 2025 Zhang, Mo, Dong, Zeng, Li, Wu, Wang and Dai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Guoan Wang, guoanwang1@163.com
Hongyan Dai, drdaihy@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.